跳至主要内容
临床试验/NCT03481686
NCT03481686已完成不适用

SelfEPO - Therapeutic Education of Chronic Renal or Renal Transplant Patient in the Management of EPO Injections

Rennes University Hospital2 个研究点 分布在 1 个国家目标入组 9 人开始时间: 2018年9月21日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
9
试验地点
2
主要终点
Number of patients performing all their injections themselves and / or their spouse

研究概览

简要总结

In chronic kidney disease, ESAs (Erythropoiesis-stimulating agents) are used to treat anemia. This anemia is due to decreased renal production of erythropoietin (EPO), a hormone that stimulates the production of red blood cells in the bone marrow. Treatment of anemia increases survival, decreases morbidity and improves quality of life and exercise tolerance.

Self-administration of ASE has been encouraged for many years, notably with pens for injection, but only few patients are educated in the injection technique.

The investigators therefore wish to lead a study in the Nephrology department of Rennes University Hospital to educate the patient, or his or her spouse, on ESA injections during hospitalization, in order to empower the patient in his care, and with the second aim of reducing the costs of chronic renal insufficiency.

详细描述

Erythropoiesis-stimulating agents (ESAs) are numerous and prescribed, depending on the molecule, once a week to once a month. They have improved the management of pre-dialysis patients, increased their hemoglobin and decreased transfusion needs, improving their morbidity and mortality and quality of life.

They are administered in pre-dialysis or post-renal transplantation most often by subcutaneous injection, which can be done by the patient himself, a member of his family or a nurse. Self-administration of ASE has been encouraged for many years, notably with pens for injection, but only few pilot studies show the feasibility of these auto-injections of ASE and patient satisfaction.

In 2012, the investigators conducted a practice study whose main objective was to have a picture of ESA injection practices for pre-dialysis patients. It is an observational, epidemiological, prospective and multicentric study, carried out by a questionnaire completed by the nephrologist during a consultation.

At the end of a 6-month collection period, 143 records were collected. All the patients questioned were followed for chronic renal insufficiency, not yet dialysed and not transplanted.

The majority of patients enrolled in this study were in the maintenance phase for ASE prescription (86% versus 14% in the correction phase), the mean age was 66.4 +/- 16.9 years. In 70.2% of cases the injection is done by a nurse, compared to 24.8% of injections made by the patient himself and 4.9% by his spouse. For 86.7%, the injection was done at home, and for 60% without other associated care. The nurse therefore came only for the injection of ASE. Not surprisingly, at an equal ASE cost, the resort to a nurse is significantly more expensive.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients monitored for chronic renal failure, or for renal transplantation regardless of clearance level;
  • Patients whose disease requires regular injections of ESA (before hospitalization or since hospitalization);
  • Patients who did not realize their injection themselves before hospitalization;
  • Patients hospitalized in the nephrology department at Rennes university hospital ;
  • Obtaining free, informed and written consent;
  • Affiliation to social security.

排除标准

  • Major incapable persons and persons deprived of their liberty;
  • Dialysis patients or for whom dialysis is envisaged within 3 months;
  • Pregnant or nursing mothers;
  • Patients who are already performing their ASE injections alone;
  • Simultaneous participation in another research protocol involving the human person.

结局指标

主要结局

Number of patients performing all their injections themselves and / or their spouse

时间窗: 6 months

次要结局

  • Number of injections performed on the number of prescribed injections(6 months)
  • Injection site pain(6 months)
  • Number of patients refusing therapeutic education(6 months)
  • Number of patients performing all their injections themselves(3 months)
  • Side effects of ESA injection(6 months)
  • Number of patients who performed all their injections by their spouse(6 months)
  • Number of patients stopping self-injections(6 months)
  • Reason for stopping self-injections(6 months)
  • Percentage of injections performed by the nurse vs by themselves and / or their spouse before empowerment(6 months)
  • Reason for refusing therapeutic education(6 months)

研究者

发起方
Rennes University Hospital
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验